September 16, 2026. A new subcutaneous injection formulation for the Alzheimer's disease drug "Leqembi," "Leqembi Subcutaneous Injection 250mg Pen," has been approved. The generic name is the same as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results